4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001213900-24-101116
Director acquired 160,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2024-11-19 | Option exercise | +160,000 | 798,614 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2024-11-19 | Option exercise · Series A Non-Voting Convertible Preferred Stock | −160 | 0 | I: show line 2 in the form |
Loading xslF345X05/ownership.xml…